A less-than-encouraging clinical trial for an investigative medicine was the news driving down Incyte (NASDAQ: INCY) stock ...

AlphaQuest LLC reduced its stake in shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 79.8% during the fourth quarter, according to the company in its most recent 13F filing with the ...

Telix shares have slipped from their previous highs as global markets take a hit. Is now the time to pounce? Let's see.

News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ: ...

Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we ...

The Federal Reserve lifted confidence amid economic uncertainty, sparking optimism in the U.S. stock market. Chair Jerome ...

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...

Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Veeva Systems shines with 14% revenue growth, CRM adoption momentum, and Data Cloud innovations. Read why VEEV stock is a ...

Raymond James Financial Inc. bought a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) in the ...

For example, both Bell Potter and Goldman Sachs are positive on the company and believe it is emerging from a difficult ...